Calumet (CLMT) Expected to Announce Quarterly Earnings on Friday

Calumet (NASDAQ:CLMT) will likely be issuing its Q3 2025 results before the market opens on Friday, November 7th. Analysts expect the company to announce earnings of ($0.35) per share and revenue of $1.0614 billion for the quarter. Investors can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Friday, November 7, 2025 at 9:00 AM ET.

Calumet (NASDAQ:CLMT) last posted its quarterly earnings data on Friday, August 8th. The oil and gas company reported ($1.70) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.44) by ($1.26). The business had revenue of $1.03 billion for the quarter, compared to analyst estimates of $982.88 million. During the same quarter last year, the firm posted ($0.48) earnings per share. The firm’s quarterly revenue was down 9.4% on a year-over-year basis. On average, analysts expect Calumet to post $-3 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Calumet Stock Down 1.2%

Shares of NASDAQ CLMT opened at $19.49 on Thursday. The firm has a market cap of $1.69 billion, a price-to-earnings ratio of -3.73 and a beta of 0.98. The company’s 50-day simple moving average is $18.43 and its 200-day simple moving average is $15.84. Calumet has a 52-week low of $7.68 and a 52-week high of $23.75.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Engineers Gate Manager LP purchased a new stake in Calumet during the 2nd quarter worth about $230,000. Quantbot Technologies LP acquired a new position in shares of Calumet during the second quarter worth about $241,000. New York State Common Retirement Fund purchased a new stake in shares of Calumet during the second quarter worth approximately $343,000. The Manufacturers Life Insurance Company increased its stake in shares of Calumet by 199.9% during the second quarter. The Manufacturers Life Insurance Company now owns 34,551 shares of the oil and gas company’s stock worth $544,000 after buying an additional 23,031 shares during the period. Finally, Corient Private Wealth LLC acquired a new stake in Calumet in the second quarter valued at approximately $577,000. Hedge funds and other institutional investors own 34.41% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on CLMT. UBS Group boosted their price objective on Calumet from $12.00 to $13.25 and gave the stock a “neutral” rating in a research note on Tuesday, August 12th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Calumet in a research note on Wednesday, October 8th. Zacks Research cut Calumet from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 7th. Finally, The Goldman Sachs Group increased their price objective on Calumet from $15.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Four investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $19.71.

About Calumet

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.